Clostridioides difficile Infection, Still a Long Way to Go.

Fiche du document

Date

20 janvier 2021

Types de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3390/jcm10030389

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33498428

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2077-0383

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_C51251BBC3032

Licences

info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/



Sujets proches En

Therapy

Citer ce document

E. Kampouri et al., « Clostridioides difficile Infection, Still a Long Way to Go. », Serveur académique Lausannois, ID : 10.3390/jcm10030389


Métriques


Partage / Export

Résumé 0

Clostridioides difficile is an increasingly common pathogen both within and outside the hospital and is responsible for a large clinical spectrum from asymptomatic carriage to complicated infection associated with a high mortality. While diagnostic methods have considerably progressed over the years, the optimal diagnostic algorithm is still debated and there is no single diagnostic test that can be used as a standalone test. More importantly, the heterogeneity in diagnostic practices between centers along with the lack of robust surveillance systems in all countries and an important degree of underdiagnosis due to lack of clinical suspicion in the community, hinder a more accurate evaluation of the burden of disease. Our improved understanding of the physiopathology of CDI has allowed some significant progress in the treatment of CDI, including a broader use of fidaxomicine, the use of fecal microbiota transplantation for multiples recurrences and newer approaches including antibodies, vaccines and new molecules, already developed or in the pipeline. However, the management of CDI recurrences and severe infections remain challenging and the main question remains: how to best target these often expensive treatments to the right population. In this review we discuss current diagnostic approaches, treatment and potential prevention strategies, with a special focus on recent advances in the field as well as areas of uncertainty and unmet needs and how to address them.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en